| Jane A Heisel, MD | |
|
4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 | |
| (907) 729-3971 | |
| (907) 729-1542 |
| Full Name | Jane A Heisel |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427071885 | NPI | - | NPPES |
| MD4993 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4350 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) announced today that Charity Navigator, America's premier independent evaluator of charitable organizations, has awarded the MMRF with its 4-star rating, the highest rating possible, for the ninth consecutive year - demonstrating exceptional fiscal responsibility in the MMRF's efforts to bring patients the next generation of treatments and find a cure for multiple myeloma.
A severely brain injured woman, who recovered the ability to communicate using her left eye, restored connections and function of the areas of her brain responsible for producing expressive language and responding to human speech, according to new research from Weill Cornell Medicine scientists.
A new immune-suppressing therapy has led to the longest survival yet for a cross-species heart transplant, according to new research conducted in part by researchers at the University of Maryland School of Medicine.
For the first time, Johns Hopkins researchers were able to easily jumpstart the activity of a well-known cancer protein in live cells with a small molecule, a strategy that pinpointed key players in the cancer process and can be used to determine new therapeutic targets.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 2 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) announced today that Charity Navigator, America's premier independent evaluator of charitable organizations, has awarded the MMRF with its 4-star rating, the highest rating possible, for the ninth consecutive year - demonstrating exceptional fiscal responsibility in the MMRF's efforts to bring patients the next generation of treatments and find a cure for multiple myeloma.
A severely brain injured woman, who recovered the ability to communicate using her left eye, restored connections and function of the areas of her brain responsible for producing expressive language and responding to human speech, according to new research from Weill Cornell Medicine scientists.
A new immune-suppressing therapy has led to the longest survival yet for a cross-species heart transplant, according to new research conducted in part by researchers at the University of Maryland School of Medicine.
For the first time, Johns Hopkins researchers were able to easily jumpstart the activity of a well-known cancer protein in live cells with a small molecule, a strategy that pinpointed key players in the cancer process and can be used to determine new therapeutic targets.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane A Heisel, MD 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 Ph: (907) 729-3971 | Jane A Heisel, MD 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 Ph: (907) 729-3971 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) announced today that Charity Navigator, America's premier independent evaluator of charitable organizations, has awarded the MMRF with its 4-star rating, the highest rating possible, for the ninth consecutive year - demonstrating exceptional fiscal responsibility in the MMRF's efforts to bring patients the next generation of treatments and find a cure for multiple myeloma.
A severely brain injured woman, who recovered the ability to communicate using her left eye, restored connections and function of the areas of her brain responsible for producing expressive language and responding to human speech, according to new research from Weill Cornell Medicine scientists.
A new immune-suppressing therapy has led to the longest survival yet for a cross-species heart transplant, according to new research conducted in part by researchers at the University of Maryland School of Medicine.
For the first time, Johns Hopkins researchers were able to easily jumpstart the activity of a well-known cancer protein in live cells with a small molecule, a strategy that pinpointed key players in the cancer process and can be used to determine new therapeutic targets.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 2 days ago
John E Hall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-261-3111 Fax: 907-565-8066 | |
Sandra Lee Gailey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 Fax: 907-729-1759 | |
Dr. Richard Wood, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 673 Mdg / Jb Elmendorf-richardson Usaf, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-5556 | |
William D Longhurst, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-553-2662 | |
Dr. Leigh Martinez Wright, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Alaska Native Medical Center, Anchorage, AK 99508 Phone: 907-729-1729 | |
Dr. Frank H Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-261-3111 Fax: 907-565-8066 | |
Tanya M Leinicke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-565-8005 Fax: 907-565-8066 |